This is to inform you that the Board of Directors of National Peroxide Limited at their meeting held today i.e., on April 30, 2026, had inter-alia considered and approved the following ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
National Peroxide Limited reported FY2026 revenue of Rs 28,687.40 lakh, marginally down from Rs 28,971.14 lakh in FY2025 (approx 1% decline). However, PAT surged 39% to Rs 1,103.71 lakh from Rs 792.86 lakh, driven by cost optimizations. The Board recommended a final dividend of Rs 7 per share (70%). Statutory auditors Kalyaniwalla & Mistry LLP issued an Unmodified Opinion. The auditor drew an Emphasis of Matter on proposed commission of Rs 17 lakh to Non-Executive Directors requiring shareholder approval as it exceeds Section 197 limits. An exceptional item of Rs 58.15 lakh was recorded due to Social Security Code implementation costs. Key management change: Mr. Amit Goriwale stepped down as Interim CFO & CRO effective May 31, 2026, succeeded by Mr. Chirag Kothari (Chartered Accountant with 20+ years experience) effective June 1, 2026.
Positive PAT growth of 39% despite flat revenue indicates improved operational efficiency. Dividend payment and clean audit report are shareholder-friendly. The CFO transition appears planned and non-alarming. No going concern issues identified.